Teva Rises After Sales Top Estimates on Branded Shift

Generic drug manufacturer Teva Pharmaceutical Industries Ltd. beat Wall Street estimates for the first quarter on demand for its branded medications.

The Tel Aviv-based company has been pivoting to new medications to boost its sales and away from its long dependence on generics as competition in that sector has increased.